Skip to main content
Livermore
Livermore
ZHEN

Sabby Management, LLC

SEC CIK
0001535610
Latest filing
Aug 14, 2026

Holdings in Q2 2024

Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.

Institution overview
Positions
27
−17 vs. Q1 2024
Portfolio value
$7.53M
−$7.75M (−50.7%) vs. Q1 2024
Filed
Aug 14, 2024
SEC
Holdings of Sabby Management, LLC in Q2 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
VANIVivani Medical, Inc.COMMON STOCK2,126,176$2.68M35.6%−546,842−20.5%ReducedHistory
CORZWCore Scientific, Inc.*W EXP 01/23/202168,974$762.1K10.1%+168,974NewHistory
RDHLRedHill Biopharma Ltd.SPON ADS NEW1,341,189$497.2K6.6%−978,049−42.2%ReducedHistory
GWAVGreenwave Technology Solutions, Inc.COM229,472$406.2K5.4%+229,472NewHistory
ELTKEltek LtdSHS40,565$395.5K5.3%−72,435−64.1%ReducedHistory
iShares Russell 2000 ETF464287655ETF1,500$304.3K4.0%+1,500New–
RVPHReviva Pharmaceuticals Holdings, Inc.COM236,997$303.4K4.0%+236,997NewHistory
BIVIBiovie Inc.CL A NEW733,055$293.6K3.9%+43,920+6.4%AddedHistory
LIPOLipella Pharmaceuticals Inc.COMMON STOCK540,250$243.1K3.2%+290,351+116.2%AddedHistory
SONNSonnet BioTherapeutics Holdings, Inc.COM238,395$223.5K3.0%+238,395NewHistory
SIDUSidus Space Inc.CL A COM NEW83,100$194.5K2.6%00.0%UnchangedHistory
ENSCEnsysce Biosciences, Inc.COM314,353$159.2K2.1%+83,799+36.3%AddedHistory
APVOAptevo Therapeutics Inc.COM501,499$153.5K2.0%+501,499NewHistory
GEVOGevo, Inc.COM PAR250,000$139.3K1.9%−100,000−28.6%ReducedHistory
NEXINexImmune, Inc.COM NEW49,904$137.7K1.8%−9,947−16.6%ReducedHistory
ATXIAvenue Therapeutics, Inc.COM NEW37,394$130.9K1.7%+37,394NewHistory
EFTReFFECTOR Therapeutics, Inc.COM NEW352,084$102.1K1.4%+352,084NewHistory
SMFLSmart for Life, Inc.COM NEW34,504$102.1K1.4%+34,504NewHistory
CHNRChina Natural Resources IncCOMMON104,931$82.2K1.1%−324,260−75.6%ReducedHistory
INMInMed Pharmaceuticals Inc.COM NEW307,236$81.6K1.1%−54,492−15.1%ReducedHistory
SCNIScinai Immunotherapeutics Ltd.SPONSORED ADR17,828$49.6K0.7%−7,486−29.6%ReducedConverted for a 1-for-10 splitHistory
Applied Dna Sciences Inc03815U409COM NEW70,463$28.8K0.4%+70,463New–
SXTPW60 Degrees Pharmaceuticals, Inc.*W EXP 07/12/202295,589$20.7K0.3%−11,128−3.6%ReducedHistory
WLDSWWearable Devices Ltd.*W EXP 09/14/202223,089$13.3K0.2%−142,191−38.9%ReducedHistory
AmpliTech Group, Inc.03211Q119*W EXP 01/01/202332,716$12.8K0.2%−46,328−12.2%Reduced–
SBFMSunshine Biopharma Inc.COM NEW20,000$8.35K0.1%+20,000NewHistory
CINGWCingulate Inc.*W EXP 12/03/202458,522$4.95K0.1%−10,200−2.2%ReducedHistory

Options (12)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Sabby Management, LLC in Q2 2024
SecurityClassPutsCalls
SPDR S&P 500 ETF Tr78462F953PUT$59.5M–
iShares Tr464287955PUT$50.9M–
SPDR S&P 500 ETF Tr78462F903CALL–$16.5M
iShares Tr464287905CALL–$5.96M
Core Scientific Inc New21874A956PUT$5.49M–
Bit Digital IncG1144A955PUT$1.37M–
Checkpoint Therapeutics Inc162828956PUT$582.2K–
Core Scientific Inc New21874A906CALL–$459.4K
NRX Pharmaceuticals Inc629444959COM$129.3K–
Gevo Inc374396906CALL–$70.1K
Eos Energy Enterprises Inc29415C951PUT$64.9K–
Globus Maritime Limited NewY27265956PUT$17.1K–

Sold out since Q1 2024 (28)

Positions held at the end of Q1 2024 that are gone from this filing.

Positions of Sabby Management, LLC sold out since Q1 2024
SecurityClassShares in Q1 2024Value in Q1 2024% of portfolio in Q1 2024History
Core Scientific, Inc.21874AAB2NOTE 10.000% 1/2–$1.24M8.1%–
TNXPTonix Pharmaceuticals Holding Corp.COM NEW4,895,962$910.6K6.0%History
GMMGlobal Mofy AI LtdORD SHS641,078$527.6K3.5%History
RCONRecon Technology, LtdSHS NEW2,840,592$420.4K2.8%History
AUVIApplied UV, Inc.COM NEW217,084$323.5K2.1%History
BRTXBioRestorative Therapies, Inc.COM NEW168,544$232.6K1.5%History
SUNESUNation Energy, Inc.COM3,400,134$231.2K1.5%History
RNAZTranscode Therapeutics, Inc.Stock334,823$228.7K1.5%History
GCTKGlucotrack, Inc.COM NEW614,636$203.5K1.3%History
BJDXBluejay Diagnostics, Inc.COM NEW187,293$150.4K1.0%History
Bynd Cannasoft Enterprises I05608P208COM NEW92,420$129.4K0.8%–
PCSAProcessa Pharmaceuticals, Inc.COM SHS48,601$114.9K0.8%History
ATXIAvenue Therapeutics, Inc.COM670,926$99.0K0.6%History
BCTXBriaCell Therapeutics Corp.COM34,222$97.9K0.6%History
AKTXAkari Therapeutics PlcSPONSORED ADR48,491$90.4K0.6%History
RKDAArcadia Biosciences, Inc.COM40,300$89.1K0.6%History
AZTRAzitra, Inc.COM425,257$87.4K0.6%History
IBIOiBio, Inc.COM NEW14,000$56.8K0.4%History
CORZZCore Scientific, Inc.*W EXP 01/23/20214,497$34.8K0.2%History
Invo Bioscience Inc44984F401COM NEW18,624$21.0K0.1%–
SPCBSuperCom LtdSHS121,781$20.2K0.1%History
SPIRSpire Global, Inc.COM CL A NEW1,518$18.2K0.1%History
TCToken Cat LtdADR4,179$6.44K<0.1%History
CNEYCN Energy Group. Inc.CLASS A ORD5,000$5.30K<0.1%History
LUCYWInnovative Eyewear Inc*W EXP 08/16/202103,798$5.24K<0.1%History
NEXRWNexera Technologies Ltd*W EXP 08/26/20276,646$4.48K<0.1%History
SNESSenesTech, Inc.COM NEW6,260$4.27K<0.1%History
GWAVGreenwave Technology Solutions, Inc.COM NEW6,996$847<0.1%History